| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.0051 | 1 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.01 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0013 | 1 |